Breakthroughs in Action 2025
In 2025 we funded the following research:
Maria Basil, MD, PhD
Uncovering Clonal Epithelial Dysregulation in Lung Cancer and Associated Risk Factors
Meghan Logun, PhD:
Novel Porcine Brain-Derived Hydrogel Carrier for Intratumoral Administration of CAR T Cells in Post-Resection GB
Ahmed Diab, PhD
Ex Vivo Tumor Slice Cultures to Develop Targeted Therapy Combinations that Potentiate Immunotherapy Responses in HPV+ Head and Neck Cancers
Roger Kim, MD, PhD
Examining Clinician Perceptions of Pulmonary Nodule Risk Stratification ToolsAndrew Zahrt, PhD
Automation and Machine-Learning-Driven Exploration of Linker-Space for PROTAC Optimization